EVpedia 2.0

This menu provides the list of EV miRNAs identified by high-throughput analyses.

Search:

Superdomain: All Prokaryote Eukaryote

Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).

Maximum false positive rate (FPR): Maximum true positive rate (TPR):
  - FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
  - TPR is the percentile of miRNA among the present miRNAs.
    Please see user manual in the contact us/help menu for detail.

Number of molecules in one page:

Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.

Mature name	miRBase accession	FPR	TPR	Publication	Orthologous group	Identification count All / Prokaryote / Eukaryote (FPR<0.05,TPR<0.5)
hsa-miR-24-3p	MIMAT0000080	0.0e+0	3.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000041_2	59 / 0 / 59
hsa-miR-24-3p	MIMAT0000080	0.0e+0	3.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000041_2	59 / 0 / 59
hsa-miR-25-3p	MIMAT0000081	0.0e+0	4.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000013_2	73 / 0 / 73
hsa-miR-25-3p	MIMAT0000081	0.0e+0	4.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000013_2	73 / 0 / 73
hsa-miR-27a-3p	MIMAT0000084	0.0e+0	4.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000036_2	80 / 0 / 80
hsa-miR-27b-3p	MIMAT0000419	0.0e+0	3.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000036_2	80 / 0 / 80
hsa-miR-27b-3p	MIMAT0000419	0.0e+0	2.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000036_2	80 / 0 / 80
hsa-miR-2861	MIMAT0013802	0.0e+0	2.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000963_1	47 / 0 / 47
hsa-miR-2861	MIMAT0013802	0.0e+0	1.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000963_1	47 / 0 / 47
hsa-miR-29a-3p	MIMAT0000086	0.0e+0	3.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000009_2	62 / 0 / 62
hsa-miR-31-5p	MIMAT0000089	0.0e+0	4.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000064_1	34 / 0 / 34
hsa-miR-3135b	MIMAT0018985	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001219_1	20 / 0 / 20
hsa-miR-3138	MIMAT0015006	0.0e+0	2.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001428_1	21 / 0 / 21
hsa-miR-3138	MIMAT0015006	0.0e+0	2.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001428_1	21 / 0 / 21
hsa-miR-3141	MIMAT0015010	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	36 / 0 / 36
hsa-miR-3141	MIMAT0015010	0.0e+0	4.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	36 / 0 / 36
hsa-miR-3156-5p	MIMAT0015030	0.0e+0	3.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000891_1	16 / 0 / 16
hsa-miR-3156-5p	MIMAT0015030	0.0e+0	3.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000891_1	16 / 0 / 16
hsa-miR-3162-5p	MIMAT0015036	0.0e+0	2.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	34 / 0 / 34
hsa-miR-3162-5p	MIMAT0015036	0.0e+0	2.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	34 / 0 / 34
hsa-miR-3195	MIMAT0015079	0.0e+0	2.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	24 / 0 / 24
hsa-miR-3195	MIMAT0015079	0.0e+0	3.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	24 / 0 / 24
hsa-miR-3196	MIMAT0015080	0.0e+0	1.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	36 / 0 / 36
hsa-miR-3196	MIMAT0015080	0.0e+0	1.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	36 / 0 / 36
hsa-miR-320a	MIMAT0000510	0.0e+0	3.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000163_1	83 / 0 / 83
hsa-miR-320a	MIMAT0000510	0.0e+0	2.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000163_1	83 / 0 / 83
hsa-miR-320b	MIMAT0005792	0.0e+0	2.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000163_1	83 / 0 / 83
hsa-miR-320b	MIMAT0005792	0.0e+0	2.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000163_1	83 / 0 / 83
hsa-miR-320c	MIMAT0005793	0.0e+0	1.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000163_1	83 / 0 / 83
hsa-miR-320c	MIMAT0005793	0.0e+0	1.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000163_1	83 / 0 / 83
hsa-miR-320d	MIMAT0006764	0.0e+0	4.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000163_1	83 / 0 / 83
hsa-miR-320d	MIMAT0006764	0.0e+0	4.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000163_1	83 / 0 / 83
hsa-miR-320e	MIMAT0015072	0.0e+0	4.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000163_1	83 / 0 / 83
hsa-miR-324-3p	MIMAT0000762	0.0e+0	5.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000165_2	47 / 0 / 47
hsa-miR-324-3p	MIMAT0000762	0.0e+0	4.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000165_2	47 / 0 / 47
hsa-miR-34a-5p	MIMAT0000255	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000039_1	51 / 0 / 51
hsa-miR-34a-5p	MIMAT0000255	0.0e+0	3.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000039_1	51 / 0 / 51
hsa-miR-3648	MIMAT0018068	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001984_1	26 / 0 / 26
hsa-miR-3648	MIMAT0018068	0.0e+0	4.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001984_1	26 / 0 / 26
hsa-miR-3656	MIMAT0018076	0.0e+0	2.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	43 / 0 / 43
hsa-miR-3656	MIMAT0018076	0.0e+0	2.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	43 / 0 / 43
hsa-miR-3659	MIMAT0018080	0.0e+0	3.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	6 / 0 / 6
hsa-miR-3659	MIMAT0018080	0.0e+0	3.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	6 / 0 / 6
hsa-miR-3659	MIMAT0018080	0.0e+0	3.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	6 / 0 / 6
hsa-miR-365a-3p	MIMAT0000710	0.0e+0	3.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000061_2	35 / 0 / 35
hsa-miR-365a-3p	MIMAT0000710	0.0e+0	3.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000061_2	35 / 0 / 35
hsa-miR-365a-5p	MIMAT0009199	0.0e+0	4.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000061_1	14 / 0 / 14
hsa-miR-365b-5p	MIMAT0022833	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000061_1	14 / 0 / 14
hsa-miR-3660	MIMAT0018081	0.0e+0	5.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001397_1	4 / 0 / 4
hsa-miR-3663-3p	MIMAT0018085	0.0e+0	4.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	19 / 0 / 19
hsa-miR-3665	MIMAT0018087	0.0e+0	2.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	39 / 0 / 39
hsa-miR-3665	MIMAT0018087	0.0e+0	1.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	39 / 0 / 39
hsa-miR-3667-5p	MIMAT0018089	0.0e+0	3.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	11 / 0 / 11
hsa-miR-3667-5p	MIMAT0018089	0.0e+0	3.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	11 / 0 / 11
hsa-miR-3679-5p	MIMAT0018104	0.0e+0	3.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	23 / 0 / 23
hsa-miR-3679-5p	MIMAT0018104	0.0e+0	2.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	23 / 0 / 23
hsa-miR-371a-5p	MIMAT0004687	0.0e+0	2.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000068_1	47 / 0 / 47
hsa-miR-371a-5p	MIMAT0004687	0.0e+0	2.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000068_1	47 / 0 / 47
hsa-miR-371a-5p	MIMAT0004687	0.0e+0	2.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000068_1	47 / 0 / 47
hsa-miR-371b-5p	MIMAT0019892	0.0e+0	3.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000068_1	47 / 0 / 47
hsa-miR-371b-5p	MIMAT0019892	0.0e+0	3.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000068_1	47 / 0 / 47
hsa-miR-378a-3p	MIMAT0000732	0.0e+0	4.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000168_2	24 / 0 / 24
hsa-miR-378a-3p	MIMAT0000732	0.0e+0	4.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000168_2	24 / 0 / 24
hsa-miR-3907	MIMAT0018179	0.0e+0	4.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	9 / 0 / 9
hsa-miR-3907	MIMAT0018179	0.0e+0	3.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	9 / 0 / 9
hsa-miR-3926	MIMAT0018201	0.0e+0	3.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001118_1	6 / 0 / 6
hsa-miR-3926	MIMAT0018201	0.0e+0	3.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001118_1	6 / 0 / 6
hsa-miR-3934-5p	MIMAT0018349	0.0e+0	1.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001584_1	12 / 0 / 12
hsa-miR-3934-5p	MIMAT0018349	0.0e+0	1.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001584_1	12 / 0 / 12
hsa-miR-3937	MIMAT0018352	0.0e+0	4.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001500_1	23 / 0 / 23
hsa-miR-3937	MIMAT0018352	0.0e+0	4.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001500_1	23 / 0 / 23
hsa-miR-3940-5p	MIMAT0019229	0.0e+0	3.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001599_1	21 / 0 / 21
hsa-miR-3945	MIMAT0018361	0.0e+0	4.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	9 / 0 / 9
hsa-miR-3945	MIMAT0018361	0.0e+0	4.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	9 / 0 / 9
hsa-miR-3960	MIMAT0019337	0.0e+0	9.4e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001271_1	42 / 0 / 42
hsa-miR-3960	MIMAT0019337	0.0e+0	9.0e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001271_1	42 / 0 / 42
hsa-miR-3976	MIMAT0019361	0.0e+0	3.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	6 / 0 / 6
hsa-miR-3976	MIMAT0019361	0.0e+0	3.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	6 / 0 / 6
hsa-miR-421	MIMAT0003339	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000098_1	27 / 0 / 27
hsa-miR-421	MIMAT0003339	0.0e+0	3.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000098_1	27 / 0 / 27
hsa-miR-422a	MIMAT0001339	0.0e+0	4.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000548_1	38 / 0 / 38
hsa-miR-422a	MIMAT0001339	0.0e+0	4.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000548_1	38 / 0 / 38
hsa-miR-422a	MIMAT0001339	0.0e+0	4.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000548_1	38 / 0 / 38
hsa-miR-423-5p	MIMAT0004748	0.0e+0	5.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000329_1	40 / 0 / 40
hsa-miR-423-5p	MIMAT0004748	0.0e+0	3.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000329_1	40 / 0 / 40
hsa-miR-4252	MIMAT0016886	0.0e+0	1.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	14 / 0 / 14
hsa-miR-4252	MIMAT0016886	0.0e+0	1.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	14 / 0 / 14
hsa-miR-4253	MIMAT0016882	0.0e+0	5.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	19 / 0 / 19
hsa-miR-4257	MIMAT0016878	0.0e+0	2.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-4257	MIMAT0016878	0.0e+0	2.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-4259	MIMAT0016880	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	13 / 0 / 13
hsa-miR-4261	MIMAT0016890	0.0e+0	4.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	14 / 0 / 14
hsa-miR-4261	MIMAT0016890	0.0e+0	2.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	14 / 0 / 14
hsa-miR-4270	MIMAT0016900	0.0e+0	2.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	39 / 0 / 39
hsa-miR-4270	MIMAT0016900	0.0e+0	2.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	39 / 0 / 39
hsa-miR-4271	MIMAT0016901	0.0e+0	3.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	27 / 0 / 27
hsa-miR-4271	MIMAT0016901	0.0e+0	3.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	27 / 0 / 27
hsa-miR-4281	MIMAT0016907	0.0e+0	1.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	39 / 0 / 39
hsa-miR-4281	MIMAT0016907	0.0e+0	1.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	39 / 0 / 39
hsa-miR-4284	MIMAT0016915	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	12 / 0 / 12

< [574] [575] [576] [577] [578] [579] [580] [581] [582] [583] >